Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin in type 2 diabetes mellitus with congestive heart failure
2008-005012-41Phase 3Completed
- Sponsor
- Novartis
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) and heart failure (HF) comparing Vildagliptin with Placebo (2 arms). Started Mar 2009; status: completed.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)heart failure (HF)
Beyond the preview
Go deeper on 2008-005012-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005012-41.